Skip to main
SLGL

Sol-Gel Technologies (SLGL) Stock Forecast & Price Target

Sol-Gel Technologies (SLGL) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Sol-Gel Technologies Ltd has seen a significant upward revision in its financial projections, with an increase in peak annual sales per patient from $150K to $250K, indicating strong market potential for its products. The anticipated approval of SGT-610, which aims to prevent new basal cell carcinoma lesions in Gorlin syndrome patients, could generate annual peak revenues exceeding $300 million, further enhancing the company's growth outlook. Additionally, the potential for self-commercialization is highlighted by the manageable size of the Gorlin syndrome market, estimated at around 11,000 patients in the U.S., providing a favorable landscape for Sol-Gel's product offerings.

Bears say

Sol-Gel Technologies Ltd faces several significant risks that contribute to a negative outlook on its stock. The pivotal trial for SGT-610 in Gorlin syndrome may fail to generate positive results, which could hinder regulatory approval and further development. Additionally, setbacks in other programs, such as the discontinued SGT-210, combined with the potential for medium- to long-term dilution risk after a recent reverse stock split, undermine investor confidence and overall financial stability.

Sol-Gel Technologies (SLGL) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sol-Gel Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sol-Gel Technologies (SLGL) Forecast

Analysts have given Sol-Gel Technologies (SLGL) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Sol-Gel Technologies (SLGL) has a Strong Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $110, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $110, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sol-Gel Technologies (SLGL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.